Vanderbilt Transplant Center

The year 2020 will forever be defined by the global COVID-19 pandemic, and Vanderbilt University Medical Center’s response to it has been nothing short of stunning. The entire enterprise — clinical, research and education — began preparing for the pandemic’s impact even before the first cases appeared in Tennessee in March, and that dedicated commitment and unceasing effort did not waver in the long months that followed. But while COVID-19 dominated the news during 2020, there were still many other noteworthy achievements that made headlines during the year.

Liver transplants have traditionally required a high volume of transfusions of blood products, which comes with several downsides. The products are costly to patients — as high as $15,000 on top of the expense of a transplant. And they are sometimes not well accepted in patients because they degrade over time and are derived from multiple patients.

Her brother Taylor's death was heartbreaking, but Anna Lorenz is determined to inspire others with his example

The Vanderbilt Transplant Center's newly launched living liver donor program allows relatives to donate part of their liver to their loved one, something only possible at select centers in the country.

Matthew Bacchetta, MD, MBA, MA, associate professor of Thoracic Surgery, has been named associate chair of Vanderbilt University Medical Center’s Department of Thoracic Surgery, effective Sept. 1.

Vanderbilt University Medical Center has completed its 10,000th organ transplant, a monumental achievement representing nearly 60 years of life-saving work.